Navigation Links
Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
Date:1/3/2008

September 30, 2007. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
3. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
4. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
5. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
6. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
7. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
8. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
9. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
10. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
11. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... 6 Derma Sciences, Inc...nced wound care products, announced plans to relea... Monday, November 16, 2009. The Company will hold ...ults at 11:00 am EST. Interested parties should ca...ternational), with passcode 81416481 to access the...
(Date:11/6/2009).... 6 Philips Respironics applauds t...Prevention (CDC) to raise awareness about an impor...iency. The CDC,s release of the first-ever governm... sleeplessness is a milestone in quantifying the s...e educator, industry leader and sleep therapy manu...
(Date:11/6/2009)...wswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CY...financial results for the second quarter ended Oct...2010 on Wednesday, November 18, 2009 at 5:00 PM ES...discuss those results on Thursday, November 19, 20... Quarter Results Conference Call Instructions ,...
Breaking Medicine Technology:Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Sedentary Kids May Take Longer to Fall Asleep 52576 1Sedentary Kids May Take Longer to Fall Asleep 52576 2Sedentary Kids May Take Longer to Fall Asleep 52576 3Stripping leukemia initiating cells of their invisibility cloak 52573 1Stripping leukemia initiating cells of their invisibility cloak 52573 2Detecting early signs of osteoarthritis 52570 1Detecting early signs of osteoarthritis 52570 2
...HOVOT Israel, February 12 ,Rosetta Genomics Ltd. (...ivo,efficacy data for a systemic microRNA-based ca...ted a marked suppression of a microRNA that was,fo...carcinoma (HCC), and a,significant two-fold reduct...at the Keystone Symposium, Therapeutic Modulation ...
...surgery hormone therapy reduced risk of breast can...py alone , , - First Phase III data to substantia...e most widely prescribed drug for prevention of bo... than 2.7 million patients treated worldwide , , ...wly published study in The New England Journal of...
Other Medicine Technology:Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 2Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 3Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 4Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 5Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 2Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 3Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 4Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 5Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 6Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 7
(Date:11/8/2009)...network of Hispanic health advocates committed to ..., WASHINGTON, Nov. 7 ... they have heard the voice of America,s families b...ct. Now the Senate must deliver, without delay, on...id Dr. Jane L. Delgado, President and CEO of the N...
(Date:11/8/2009)...assage of H.R. 3961 to Secure the Stability of Med...e/ -- Statement Attributable to: J. James Rohack, ..., (Logo: http://www.newscom.com/cgi-bin/prnh/20...e of the House health reform bill, which will help...ians and calls for swift passage of H.R. 3961 to s...
(Date:11/8/2009)...Shows Who Sides With Working Families vs. Insuranc...wire-USNewswire/ -- On the heels of an historic la...a good, balanced health care reform bill, the Penn...tate,s U.S. representatives voted on HR 3962, the ... legislation, which passed Saturday evening by a v...
(Date:11/7/2009)... Karen Ignagni, Preside...IP), released the following statement today on Hou...gly support comprehensive health care reform, and ...g a complete overhaul of how health insurance is p... coverage, elimination of pre-existing condition e...
(Date:11/7/2009)...RNewswire-USNewswire/ -- The American Medical Asso...or of Health at the Family Violence Prevention Fun...ay at its semi-annual policy-making meeting. The ...honor the AMA House of Delegates bestows on a non-...m/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ms. Jam...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Family Violence Prevention Expert 2
... on animal health has declared India as free from ...disease affecting the intestinal tract of cattle /...inderpest infection is a great achievement. It is ...ministry said in a statement Friday. 'This f...
...ader Sri Sri Ravishankar has said practising yoga,...away from drug and alcohol abuse. // 'Youths...to introduce yoga, pranayam and dhyan (meditation)...vi Shankar appealed to the youths to take up yoga ...
...rotests witnessed last month against the governmen...tions of higher education were a creation //of the...id here Friday 'The resistance (to the propo...ntral educational institutions, he said all politi...
... the research conducted by the U.S. Department of ...gues at Stony Brook University // , the IRCCS Neur...rsity it was found that improvements in the existi...ially tested on rats and the results of the study ...
...he Pentagon placed new restrictions on a doctors’...ere against any policy //that gives medical profe...ogaters’ to use harsher tactics than they would i... rights groups and medical ethicists. They charge ...
...government has cancelled examinations for recruitm... thereby providing more opportunities // to over 1...o low demand, we have cancelled all PLAB (Professi...t announced. Shiv Pande, Chairman of Indo-Bri...
Other Medicine News:Health News:India Declared Free of Rinderpest Cattle Infection 2Health News:Radiation Therapy Made More Compatible 2Health News:Radiation Therapy Made More Compatible 3Health News:Medical Role In Interrogations Curtailed By Pentagon 2
E300 Corneal Topographer
...NPstream Genotyping System provides an automated s... over 800,000 SNP genotypes per day. Combined with...nd operational flexibility, this enables you to pr...st solution designed to deliver your intended resu...
...e upgrade including fourSight 4D ultrasound imagin...ystem offers a wide variety of imaging and workflo...atures that combine to expand the clinical capabil...ares system was built on four foundations that mar...
... laser-cut stent, is the latest in a succession of...y arteries have been opened with balloon catheters...oronary angioplasty (PTCA). The BeStent2 stent sys...optimize scaffolding, radiopacity and deliverabili...
Medicine Products: